A leading player in home healthcare for the last 30 years, Air Liquide is a key partner for addressing these changes. The Group aims, in particular, to provide lasting responses to the challenges posed by the global increase in chronic diseases. Thanks to its recognized expertise and its close relationships with doctors and patients, the Group has acquired a strong legitimacy in the field of home healthcare by helping preserve the quality of life and independence of patients, while helping control healthcare spendings.
Air Liquide consolidates its position in Saudi Arabia
Air Liquide, which already operates in the Saudi Arabian healthcare sector by supplying medical gases to hospitals, expanded its activities in the country in 2018 with the acquisition of the respiratory division of Thimar Al Jazirah Company (TAC), a key local player in the pharmaceutical, medical, and dental industries, that provides home healthcare to more than 1,400 patients throughout the country. With this acquisition, the Group has managed to consolidate its position in a region that boasts significant potential. With more than 32 million inhabitants, growing healthcare needs – in particular due to the prevalence of diabetes – and a pledge from the public authorities to improve the quality of services, the home healthcare sector in Saudi Arabia has significant growth potential.
Article published on May 24, 2019